Leidos reported $1.3 billion in revenues for the third quarter of 2015, up 2 percent from $1.28 billion in the third quarter of 2015.
MedAssets‘ stock has a price target of $39.60 per share after hitting a new 52-week high, according to a Financial Magazin report.
McKesson posted a 10 percent growth in revenue for the second quarter of 2016, but gross profit dipped from $2.86 million last year to $2.84 million this year.
Mediware Information Systems, a post-acute care software company, expanded its denial management solutions offerings through its partnership with ZirMed.
If you have a question, issue or note to suggest on revenue cycle management company, please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on finance issues:
Cleveland Clinic vs. Mayo Clinic: 5 key comparisons, 2 amazing institutions
House approves budget deal that includes payment cuts to HOPDs
RCM tip of the day: Use comparative metrics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
